David A. Whipple

1.8k total citations
15 papers, 466 citations indexed

About

David A. Whipple is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, David A. Whipple has authored 15 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Organic Chemistry. Recurrent topics in David A. Whipple's work include Chemical Synthesis and Analysis (4 papers), Mass Spectrometry Techniques and Applications (2 papers) and Peptidase Inhibition and Analysis (2 papers). David A. Whipple is often cited by papers focused on Chemical Synthesis and Analysis (4 papers), Mass Spectrometry Techniques and Applications (2 papers) and Peptidase Inhibition and Analysis (2 papers). David A. Whipple collaborates with scholars based in United States, Australia and Canada. David A. Whipple's co-authors include Jasbir Singh, Mark A. Ator, Martin P. Allen, Adi M. Treasurywala, Biswarup Mukhopadhyay, Steven M. Patrie, Neil L. Kelleher, John Quinn, Alan G. Marshall and Christopher L. Hendrickson and has published in prestigious journals such as Journal of the American Chemical Society, Blood and Journal of Political Economy.

In The Last Decade

David A. Whipple

14 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David A. Whipple United States 11 211 80 75 66 50 15 466
Séverine Mollard France 11 444 2.1× 225 2.8× 61 0.8× 13 0.2× 49 1.0× 14 821
Hans‐Georg Capraro Switzerland 12 507 2.4× 214 2.7× 181 2.4× 43 0.7× 30 0.6× 24 926
Michèle Masquelier Sweden 17 427 2.0× 218 2.7× 103 1.4× 27 0.4× 90 1.8× 34 962
Noriaki Tatsuta United States 12 426 2.0× 125 1.6× 123 1.6× 17 0.3× 21 0.4× 21 731
Bryan A. Bernat United States 14 620 2.9× 260 3.3× 69 0.9× 12 0.2× 48 1.0× 16 955
Christopher E. Whitehead United States 10 291 1.4× 112 1.4× 77 1.0× 20 0.3× 27 0.5× 25 461
Eric Okerberg United States 12 453 2.1× 138 1.7× 124 1.7× 118 1.8× 28 0.6× 21 676
Catherine Chabot Canada 17 526 2.5× 110 1.4× 131 1.7× 14 0.2× 33 0.7× 25 833
Kelly G. Sprankle United States 9 545 2.6× 91 1.1× 262 3.5× 19 0.3× 22 0.4× 11 1.0k
Sandra Handschuh Germany 11 228 1.1× 58 0.7× 208 2.8× 33 0.5× 28 0.6× 14 538

Countries citing papers authored by David A. Whipple

Since Specialization
Citations

This map shows the geographic impact of David A. Whipple's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Whipple with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Whipple more than expected).

Fields of papers citing papers by David A. Whipple

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Whipple. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Whipple. The network helps show where David A. Whipple may publish in the future.

Co-authorship network of co-authors of David A. Whipple

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Whipple. A scholar is included among the top collaborators of David A. Whipple based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Whipple. David A. Whipple is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Alontaga, Aileen Y., Yifei Li, Chih‐Hong Chen, et al.. (2015). Design of High-Throughput Screening Assays and Identification of a SUMO1-Specific Small Molecule Chemotype Targeting the SUMO-Interacting Motif-Binding Surface. ACS Combinatorial Science. 17(4). 239–246. 5 indexed citations
2.
Spicer, Timothy, Virneliz Fernández-Vega, Peter Chase, et al.. (2014). Identification of Potent and Selective Inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PfM18AAP) of Human Malaria via High-Throughput Screening. SLAS DISCOVERY. 19(7). 1107–1115. 16 indexed citations
3.
Frankowski, Kevin J., Kimberly M. Lovell, Angela M. Phillips, et al.. (2014). Potency enhancement of the κ-opioid receptor antagonist probe ML140 through sulfonamide constraint utilizing a tetrahydroisoquinoline motif. Bioorganic & Medicinal Chemistry. 23(14). 3948–3956. 6 indexed citations
4.
Hedrick, Michael P., Kevin J. Frankowski, David A. Whipple, et al.. (2010). Selective KOP Receptor Antagonists: Probe 1.
5.
Changelian, Paul S., Deborah Moshinsky, Cyrille Kuhn, et al.. (2007). The specificity of JAK3 kinase inhibitors. Blood. 111(4). 2155–2157. 83 indexed citations
6.
Patrie, Steven M., David A. Whipple, Neil L. Kelleher, et al.. (2004). Construction of a hybrid quadrupole/fourier transform ion cyclotron resonance mass spectrometer for versatile MS/MS above 10 kDa. Journal of the American Society for Mass Spectrometry. 15(7). 1099–1108. 91 indexed citations
7.
Ripin, David H. Brown, Stefan Abele, Weiling Cai, et al.. (2002). Development of a Scaleable Route for the Production ofcis-N-Benzyl-3-methylamino-4-methylpiperidine. Organic Process Research & Development. 7(1). 115–120. 28 indexed citations
8.
Lyssikatos, Joe, Thomas V. Magee, J.W. Petitpas, et al.. (1997). Cyclic homopentapeptides 3. Synthetic modifications to the capreomycins and tuberactinomycins: Compounds with activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. Bioorganic & Medicinal Chemistry Letters. 7(9). 1149–1152. 11 indexed citations
9.
Singh, Jasbir, Mark A. Ator, Edward P. Jaeger, et al.. (1996). Application of Genetic Algorithms to Combinatorial Synthesis:  A Computational Approach to Lead Identification and Lead Optimization,. Journal of the American Chemical Society. 118(7). 1669–1676. 80 indexed citations
10.
11.
Singh, Jasbir, Martin P. Allen, Mark A. Ator, et al.. (1995). Validation of Screening Immobilized Peptide Libraries for Discovery of Protease Substrates. Journal of Medicinal Chemistry. 38(2). 217–219. 12 indexed citations
12.
Singh, Jasbir, James A. Gainor, Judith A. Johnson, et al.. (1995). Relationship between structure and bioavailability in a series of hydroxamate based metalloprotease inhibitors. Bioorganic & Medicinal Chemistry Letters. 5(4). 337–342. 28 indexed citations
13.
MacRae, Scott, R. Doyle Stulting, David A. Whipple, et al.. (1991). Corneal Ulcer and Adverse Reaction Rates in Premarket Contact Lens Studies. American Journal of Ophthalmology. 111(4). 457–465. 46 indexed citations
14.
Sprafka, J. Michael, et al.. (1988). Response of Diabetic Patients to a Community-Based Education Program. The Diabetes Educator. 14(2). 148–151. 3 indexed citations
15.
Whipple, David A.. (1973). A Generalized Theory of Job Search. Journal of Political Economy. 81(5). 1170–1188. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026